ORPHA:85436
Psoriasis-related juvenile idiopathic arthritis
Also known as: Juvenile psoriatic arthritis · Psoriasis-related JIA
Publications
391
73.1th percentile
Trials
12
Interventional, condition-specific
Researchers
1,206
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare pediatric inflammatory rheumatic disease characterized by the presence of arthritis accompanied by either psoriasis or at least two of the following supporting features; presence of nail pitting, onycholysis, dactylitis, or a family history of psoriasis in a first degree relative. Patients are younger than 16 years of age and the disease lasts longer than 6 weeks.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019436
- UMLS:C3714758
- NCIT:C114361
Additional Mondo synonyms (3)
JPsA · juvenile psoriatic arthritis · psoriasis-related JIA
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
391 matched papers (268 in last 10 years) Source
- Phenotype characterisedPresent
29 HPO annotations (e.g. Pruritus; Antinuclear antibody positivity; Psoriasiform dermatitis) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
12 matched on ClinicalTrials.gov (6 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
29
Associated phenotypes · MONDO:0019436
- Pruritus
- Antinuclear antibody positivity
- Psoriasiform dermatitis
- Limitation of joint mobility
- Abnormality of the wrist
Showing 5 of 29 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
12
Drugs / clinical candidates · MONDO_0019436
- ADALIMUMAB·phase 3
- APREMILAST·phase 3
- BARICITINIB·phase 3
- BIMEKIZUMAB·phase 3
- DEUCRAVACITINIB·phase 3
- GOLIMUMAB·phase 3
- GUSELKUMAB·phase 3
- METHOTREXATE·phase 3
- RISANKIZUMAB·phase 3
- SECUKINUMAB·phase 3
- USTEKINUMAB·phase 3
- TOFACITINIB·unknown
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
391
391 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
391 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
268 in the last 10 years · medium confidence · 73.1th percentile (publications denominator)
Phrase hits: 391 · MeSH hits: 0
Who's working on it?
1,206
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Brunner HI14 papers · 2026
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Papers in Europe PMC - 02Ruperto N11 papers · 2026
Università degli Studi di Milano-Bicocca, Milan, Italy.
Papers in Europe PMC - 03Weiss PF10 papers · 2026
Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Papers in Europe PMC - 04Aalto K8 papers · 2025
Department of Pediatrics, Children's Hospital, Helsinki University Hospital, Helsinki, Finland.
Papers in Europe PMC - 05Berntson L8 papers · 2026
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden. lillemor.berntson@telia.com.
Papers in Europe PMC - 06Lovell DJ7 papers · 2026
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Papers in Europe PMC - 07Ramanan AV6 papers · 2026
Bristol Royal Hospital for Children & Translational Health Sciences, University of Bristol, Bristol, United Kingdom.
Papers in Europe PMC - 08Brandon TG5 papers · 2024
Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Papers in Europe PMC - 09Ciurtin C5 papers · 2026
Centre for Adolescent Rheumatology, Department of Ageing, Rheumatology and Regenerative Medicine, Division of Medicine, University College London, London, UK.
Papers in Europe PMC - 10Fasth A5 papers · 2025
Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
12
interventional trials for this specific condition
12 interventional trials matched this specific condition name; 6 currently recruiting in our sample. 173 trials are registered for juvenile idiopathic arthritis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
12 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 93.2th percentile).
medium confidence · 93.2th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
12 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT04804553·RECRUITING·Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Not reviewed·Conditions: Active Juvenile Psoriatic Arthritis·Matched via name phrase
- NCT06100744·RECRUITING·A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Not reviewed·Conditions: Juvenile Psoriatic Arthritis·Matched via name phrase
- NCT06869551·RECRUITING·A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Not reviewed·Conditions: Juvenile Psoriatic Arthritis·Matched via name phrase
- NCT06668181·RECRUITING·An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Not reviewed·Conditions: Enthesitis-related Arthritis · Juvenile Psoriatic Arthritis·Matched via name phrase
- NCT05767047·RECRUITING·A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
Not reviewed·Conditions: Behçet's Disease · Juvenile Psoriatic Arthritis·Matched via name phrase
- NCT06751238·RECRUITING·Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
Not reviewed·Conditions: Juvenile Psoriatic Arthritis·Matched via name phrase
Broader category: juvenile idiopathic arthritis
173
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07184450·RECRUITING·Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Not reviewed·Conditions: Juvenile Dermatomyositis (JDM) · Polyarticular Juvenile Idiopathic Arthritis · Systemic Sclerosis (SSc) · Primary Sjogren's Syndrome·Matched via name phrase
- NCT07386587·ENROLLING BY INVITATION·Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT05984758·NOT YET RECRUITING·Imaging Based Uveitis Screening for Children With Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Uveitis, Anterior · Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT02991469·RECRUITING·A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT06376149·RECRUITING·M3-JIA: Making Mindfulness Matter for Children With JIA
Not reviewed·Conditions: Juvenile Idiopathic Arthritis · Children · Mental Health · Mental Well-being·Matched via name phrase
- NCT06184100·RECRUITING·Virtual Self-Management Program for JIA
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT07553182·RECRUITING·OLE Study With Filgotinib in JIA
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT06888973·ENROLLING BY INVITATION·Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases
Not reviewed·Conditions: Rheumatoid Arthritis · Systemic Lupus Erythematosus (SLE) · Systemic Sclerosis · Ankylosing Spondylitis (AS)·Matched via name phrase
- NCT07634354·NOT YET RECRUITING·Sarcopenia and Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT06618937·NOT YET RECRUITING·Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT07217782·RECRUITING·Pain in Juvenile Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT07234747·RECRUITING·Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT07661069·NOT YET RECRUITING·YOGA FOR CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT07554495·RECRUITING·Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents
Not reviewed·Conditions: Polyarticular Course Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT07087912·RECRUITING·Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Not reviewed·Conditions: Rheumatoid Arthritis (RA) · Juvenile Idiopathic Arthritis (JIA) · Systemic Lupus Erythematosus (SLE) · Juvenile Systemic Lupus Erythematosus·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07190053·NOT YET RECRUITING·Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.
Not reviewed·Conditions: Enthesitis-related Arthritis (ERA) · Juvenile Psoriatic Arthritis (JPsA)·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 23 · after dedupe 22 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 22 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (22)
- ctis·2024-517262-41-00·Authorised, ongoing·A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Children and Adolescents from 5 to less than 18 Years of Age with Active Juvenile Psoriatic Arthritis
skipped — LLM skipped (--skip-llm)
- ctis·2023-508845-41-00·Authorised, ongoing·OPEN-LABEL, SINGLE-ARM TRIAL TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF BIMEKIZUMAB IN PEDIATRIC STUDY PARTICIPANTS FROM 2 TO LESS THAN 18 YEARS OF AGE WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS SUBTYPES ENTHESITIS-RELATED ARTHRITIS (INCLUDING JUVENILE-ONSET ANKYLOSING SPONDYLITIS) AND JUVENILE PSORIATIC ARTHRITIS
skipped — LLM skipped (--skip-llm)
- ctis·2023-507144-36-00·Cancelled·A Phase 3 Multicenter, Open-label Study to Evaluate the Efficacy, Pharmacokinetics, Safety, and Immunogenicity of Subcutaneously Administered Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)
skipped — LLM skipped (--skip-llm)
- ctis·2023-503859-10-00·Expired·A MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB COMPARED TO USTEKINUMAB IN CHILDREN AND ADOLESCENT FROM 6 YEARS TO LESS THAN 18 YEARS OF AGE WITH MODERATE TO SEVERE PLAQUE PSORIASIS
skipped — LLM skipped (--skip-llm)
- ctis·2023-509560-16-00·Authorised, ongoing·A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study to Evaluate the Safety of
Guselkumab in Pediatric Participants with Crohn’s Disease, Ulcerative Colitis, or Juvenile
Psoriatic Arthritis
skipped — LLM skipped (--skip-llm)
- ctis·2023-506026-36-00·Authorised, recruiting·Open-label, randomized, assessor-blinded, efficacy, safety, tolerability, and pharmacokinetics study of subcutaneous risankizumab with an adalimumab reference arm in children with active juvenile psoriatic arthritis
skipped — LLM skipped (--skip-llm)
- ctis·2023-503435-17-00·Authorised, ongoing·A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apremilast in Children From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis (PEAPOD)
skipped — LLM skipped (--skip-llm)
- ctis·2023-503433-21-00·Authorised, ongoing·A Phase 3, Multicenter, Open-label, Long-term Extension Study of Apremilast in Children 2 Years of Age or Older With Oral Ulcers Associated With Behçet’s Disease or 5 Years of Age or Older With Juvenile Psoriatic Arthritis
skipped — LLM skipped (--skip-llm)
- ctis·2023-507184-19-00·Expired·I1F-MC-RHCG: Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab with Adalimumab Reference Arm, in Children with Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
skipped — LLM skipped (--skip-llm)
- ctis·2022-501067-40-00·Expired·A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Years of Age)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN89126536·Recruiting·The MAMA Study: Looking at the effects of stopping or continuing biologics for the treatment of inflammatory arthritis in pregnancy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN45965456·Suspended·Randomised, open-label international trial with Verapamil alone compared with Verapamil plus another immunotherapy for people with newly diagnosed type 1 diabetes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN49107623·No longer recruiting·Study to evaluate the efficacy, pharmacokinetics, safety, and immunogenicity of subcutaneously administered ustekinumab or guselkumab in pediatric participants with active juvenile psoriatic arthritis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN54174557·Recruiting·Steroid Treatment Trial in JIA (STAR-JIA): A randomised trial to compare the effectiveness, safety and cost-effectiveness of intravenous versus oral corticosteroid induction regimens for children and young people with juvenile idiopathic arthritis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN36985527·No longer recruiting·A long-term extension study of ustekinumab in pediatric participants with different medical conditions
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17691638·Recruiting·Trial of stopping or continuing biologics ahead of orthopaedic surgery
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12821688·No longer recruiting·Observational cohort trial of immune response in patients with chronic health conditions following coronavirus vaccination
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16838474·No longer recruiting·Assessing ExemptiaTM as a potential treatment for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN98851260·No longer recruiting·Developing diagnostic criteria for psoriasis in children
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN52833273·No longer recruiting·Outcomes of Periodontal Therapy in Rheumatoid Arthritis (OPERA)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN91433175·No longer recruiting·Phone call follow-up after RheumAtologIcal rehabilitation Stays: Evaluation of effects
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN61534918·No longer recruiting·Effect of Assistive Technology in patients with Hand OsteoArthritis: A randomised, controlled trial
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Psoriasis-related juvenile idiopathic arthritis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Psoriasis-related juvenile idiopathic arthritis" OR "Juvenile psoriatic arthritis" OR "Psoriasis-related JIA"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Psoriasis-related juvenile idiopathic arthritis" OR "Juvenile psoriatic arthritis" OR "Psoriasis-related JIA"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 12 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"juvenile idiopathic arthritis"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: JPsA
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T03:01:55.359Z
